Finasteride Cost in Wisconsin 2026

What Does Finasteride Actually Cost in Wisconsin Right Now?

Generic finasteride at Wisconsin retail pharmacies costs roughly $12 per month in 2026 for the 1 mg hair-loss dose. The Merck brand (Propecia at 1 mg, or Proscar at 5 mg) carries a list price near $85 per month before any insurance or discount is applied. The gap between brand and generic is large, and most Wisconsin patients never need to pay the brand-name price.

Finasteride is a 5-alpha reductase type II inhibitor approved by the FDA for androgenetic alopecia (AGA) at 1 mg and for benign prostatic hyperplasia (BPH) at 5 mg [1]. Because the patent on both strengths expired decades ago, generic competition has driven the retail price to historic lows. The FDA's current prescribing information confirms the drug's two approved indications and dose forms [1].

Price varies by pharmacy chain. GoodRx and similar programs can push the 30-tablet, 1 mg fill below $10 at certain Wisconsin locations. The 5 mg generic for BPH follows a similar trajectory and may cost even less per tablet because the pill can be split, reducing the effective monthly cost for some patients (though tablet splitting should be discussed with your prescriber before doing it, given potential exposure risks for women of childbearing age).

A 2023 analysis of androgen-deprivation cost modeling in JAMA Internal Medicine underscored how dramatically generic entry lowers out-of-pocket spending for patients on long-term hormonal therapy [2]. Finasteride's cost trajectory in Wisconsin mirrors that national pattern precisely.

Generic vs. Brand: Which Should Wisconsin Patients Choose?

Generic finasteride is therapeutically equivalent to Propecia and Proscar. The FDA's bioequivalence standards require generics to deliver the same active ingredient at the same dose within an accepted pharmacokinetic range [1]. Choosing generic over brand saves most Wisconsin patients $70 or more per month, with no clinical penalty.

Kaufman et al. studied finasteride 1 mg in a randomized, double-blind, placebo-controlled trial (N=1,553 men, 48-week treatment period) and showed that 83% of finasteride-treated men maintained or increased their hair count compared with 28% on placebo (P<0.001) [3]. That trial was conducted on the same molecule now available as a $12 generic. The therapeutic outcome does not change based on who manufactures the pill, provided the FDA has certified bioequivalence.

One practical caveat: tablet appearance and inactive excipients differ across manufacturers. A small number of patients report tolerability differences when switched between generic manufacturers, though head-to-head data on this are limited. If a Wisconsin patient notices a change after a generic switch at refill, asking the pharmacist to dispense from the same manufacturer at each fill is a reasonable step.

Compounded Finasteride in Wisconsin: Legality and Cost

Compounded finasteride from a licensed 503A pharmacy is legal in Wisconsin in 2026. The cost is typically around $45 per month, placing it between the brand-name and generic retail prices. Most patients who pay cash will still find generic retail cheaper, but compounding serves specific clinical niches.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that fill prescriptions for individual patients [4]. Wisconsin pharmacies operating under 503A must hold a valid Wisconsin Pharmacy Examining Board license and comply with USP compounding standards. The FDA does not prohibit compounding of finasteride because it is not on the FDA's "Demonstrably Difficult to Compound" list [4].

Why would a Wisconsin patient choose compounded finasteride over generic? Three common reasons arise in practice. First, some patients need a dose or form not commercially available, such as a topical finasteride preparation for scalp application. Second, patients with documented excipient allergies may need a custom formulation. Third, some telehealth platforms bundle compounded finasteride with other active ingredients (minoxidil, for instance) in a single topical or oral preparation. Prescribers should confirm the compounding pharmacy's 503A status before writing a compounding-specific prescription.

The FDA has published guidance on 503A compounding requirements that Wisconsin practitioners and pharmacies must follow [4]. Patients can verify a Wisconsin pharmacy's licensure status through the Wisconsin Department of Safety and Professional Services (DSPS) online lookup tool.

Wisconsin Medicaid Coverage for Finasteride

Wisconsin Medicaid covers finasteride, but prior authorization (PA) is required. The PA process exists because Wisconsin's ForwardHealth program differentiates between finasteride prescribed for BPH (a medical indication) and finasteride prescribed for male pattern hair loss (a cosmetic indication under many payer policies).

For BPH, prior authorization approval is generally more straightforward. The American Urological Association's 2021 guideline on benign prostatic hyperplasia recommends finasteride 5 mg as a first-line medical therapy for patients with enlarged prostates and moderate-to-severe lower urinary tract symptoms [5]. Presenting that clinical documentation supports a PA request.

For AGA, Wisconsin Medicaid PA is harder to obtain. Hair loss is commonly classified as cosmetic, and Medicaid programs across the country have historically excluded cosmetic treatments. Wisconsin providers submitting a PA for AGA-indication finasteride should document any functional or psychological impairment as part of the clinical justification.

The Wisconsin ForwardHealth portal provides current preferred drug list (PDL) status and PA criteria [6]. Providers should check the portal before prescribing, as PDL status can change with each new state fiscal year. Out-of-pocket cost for Medicaid-covered finasteride, once PA is approved, is typically a nominal copay of $1 to $3 per fill for most Wisconsin Medicaid enrollees.

Insurance Coverage for Finasteride in Wisconsin

Most commercial insurance plans in Wisconsin cover generic finasteride for BPH under Tier 1 or Tier 2 formulary placement, resulting in a copay between $5 and $20 per fill. Coverage for the AGA indication (1 mg, Propecia-labeled) is more variable and often excluded as cosmetic.

Wisconsin ACA marketplace plans sold through HealthCare.gov are required to cover FDA-approved preventive services without cost-sharing, but finasteride does not appear on the USPSTF A/B recommendation list for men [7]. That means marketplace plans are not obligated to cover it at zero cost-share. Patients should check their plan's Summary of Benefits and Coverage document or call member services to confirm formulary tier and any step-therapy requirements.

Employer-sponsored plans follow similar logic. Large self-insured employers operating under ERISA have broad latitude to exclude cosmetic treatments, and many do. However, if the prescribing diagnosis is BPH or documented prostate cancer risk reduction (finasteride holds FDA approval for risk reduction in combination with other data), the medical necessity case is stronger.

The American Hair Loss Association notes that insurance denial rates for finasteride under the AGA indication remain high across all states, not just Wisconsin [8]. Patients denied coverage have two main options: appeal using physician documentation or shift to cash-pay generic, which at $12 per month is already low enough that the appeals process may not be worth the effort for most patients.

Manufacturer and Generic Savings Programs in Wisconsin

Merck offers a savings card for Propecia that reduces out-of-pocket cost for commercially insured, non-Medicaid, non-Medicare patients. In 2026, the program has periodically capped patient cost at $30 per month for brand-name Propecia. However, at a $12 cash-pay generic price, this savings card rarely makes brand-name Propecia competitive.

GoodRx, RxSaver, and similar prescription discount programs function in Wisconsin the same way they do nationally. These programs negotiate discounted rates with pharmacy benefit managers and pass the savings to patients as a printed or digital coupon. The discount is applied at the pharmacy counter and does not require insurance. For finasteride, GoodRx typically shows prices between $7 and $15 per month at major Wisconsin chains including Walgreens, CVS, Walmart, and independent pharmacies.

NeedyMeds.org maintains a database of patient assistance programs (PAPs) for brand-name drugs. Merck's Patient Assistance Program covers Propecia for patients meeting income criteria, generally at or below 300% of the federal poverty level. Wisconsin patients without insurance who cannot afford even the generic price may qualify for this program [9].

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists finasteride 1 mg tablets at manufacturer cost plus a transparent markup, which in recent months has priced 30 tablets below $5. Wisconsin patients with a valid prescription can order through that platform and receive mail delivery, though they should confirm current pricing before ordering.

Telehealth Prescribing of Finasteride in Wisconsin

Telehealth prescribing of finasteride is legal in Wisconsin in 2026. Wisconsin follows the Ryan Haight Online Pharmacy Consumer Protection Act framework for controlled substances, but finasteride is not a controlled substance, so Ryan Haight restrictions do not apply [10]. A Wisconsin-licensed prescriber conducting a synchronous audio-visual telehealth visit can prescribe finasteride without a prior in-person visit.

Wisconsin's telehealth parity law (Wis. Stat. § 49.45(61)) requires most insurance plans to reimburse covered telehealth services at the same rate as in-person visits [11]. For patients using telehealth platforms like HealthRX, Keeps, Hims, or Ro, the prescribing visit cost is typically bundled into a subscription that ranges from $20 to $50 per month, sometimes including the medication itself.

The Federation of State Medical Boards has published a telemedicine policy framework that Wisconsin's Medical Examining Board has substantially adopted, requiring that the prescriber-patient relationship be properly established before prescribing [12]. Patients should confirm that any telehealth platform they use employs Wisconsin-licensed providers.

One practical advantage of telehealth for Wisconsin patients in rural areas: dermatologists and urologists are concentrated in Milwaukee, Madison, and Green Bay. Telehealth eliminates the geographic barrier for a patient in, say, Wausau or La Crosse who needs ongoing finasteride management.

How to Get the Lowest Finasteride Price in Wisconsin: A Step-by-Step Framework

The following framework reflects the HealthRX clinical team's approach to minimizing finasteride out-of-pocket cost for Wisconsin patients in 2026.

Step 1. Confirm the indication and dose. BPH patients (5 mg) and AGA patients (1 mg) follow different formulary and PA pathways. Confirm with your prescriber which indication is documented on the prescription. A prescription written for "androgenetic alopecia" versus "BPH" will be treated differently by every payer in Wisconsin.

Step 2. Run a GoodRx or RxSaver search before going to the pharmacy. Enter your Wisconsin ZIP code and the exact quantity (30 tablets of 1 mg, or 30 tablets of 5 mg). Prices vary by as much as 40% across pharmacies within the same city. Print or screenshot the coupon before you arrive; presenting it at the counter is required to receive the discounted rate.

Step 3. Check your insurance formulary. Log into your plan's member portal or call the number on your insurance card. Ask specifically: "Is generic finasteride 1 mg covered for androgenetic alopecia, or only for BPH?" If it is covered, ask for the Tier and the expected copay. If it requires PA, ask your prescriber to submit one. Coverage approval timelines in Wisconsin average 3 to 5 business days for standard PA and 24 hours for urgent PA.

Step 4. If uninsured or if cash-pay is cheaper, use Cost Plus Drugs or a GoodRx coupon. At $7 to $12 per month cash-pay, finasteride is one of the most affordable long-term daily medications available. Many insured patients find the coupon price beats their copay.

Step 5. Consider compounded finasteride only if a custom formulation is clinically indicated. Compounded at $45 per month, it costs 3 to 4 times more than cash-pay generic. The clinical rationale (topical formulation, excipient allergy, combination product) should justify the premium.

Step 6. For Wisconsin Medicaid patients, submit a PA with full clinical documentation. Include AUA or AAD guideline citations in the PA letter. The American Academy of Dermatology's clinical guidelines on androgenetic alopecia support finasteride 1 mg as a Grade A recommendation for male AGA [13]. A prescriber who cites that in the PA letter provides the payer with a clear evidence basis for approval.

Efficacy: Is Finasteride Worth the Cost?

Finasteride's clinical efficacy record is well-established. The Kaufman et al. 1998 randomized controlled trial (N=1,553 men, 48-week treatment) found that 83% of men on finasteride 1 mg maintained or increased hair count versus 28% on placebo [3]. Hair count at the vertex increased by a mean of 107 hairs in the finasteride group.

A longer-term extension study by Kaufman and colleagues followed men for 5 years and reported sustained hair count increases, with 90% of finasteride-treated men showing maintenance or improvement compared with continued loss in the placebo group [14]. Five years of generic finasteride at $12 per month totals $720. That is a meaningful number for many patients, but it compares favorably with hair transplant costs that typically start at $4,000 per procedure.

For BPH, the MTOPS trial (Medical Therapy of Prostatic Symptoms, N=3,047 men) demonstrated that finasteride 5 mg reduced the risk of overall clinical BPH progression by 34% compared with placebo over 4.5 years (P<0.001) [15]. The combination of finasteride plus doxazosin reduced progression risk by 67% versus placebo in that same trial.

The FDA label for finasteride 5 mg (Proscar) states directly: "Finasteride is not indicated for use in women or children." [1] That warning is relevant to Wisconsin household contexts where the drug must be stored safely away from women who are or may become pregnant, as crushed or broken tablets carry a risk of fetal harm from dermal absorption.

Side Effects That May Affect Adherence and Long-Term Cost Planning

Side effects influence whether a Wisconsin patient stays on finasteride long enough to see benefit. Finasteride must be taken daily for at least 3 months before hair effects are visible, and full benefit takes 12 months or longer. Stopping the drug reverses gains within 6 to 12 months.

The most discussed side effects are sexual: decreased libido, erectile dysfunction, and reduced ejaculate volume. In the original Merck-sponsored trials, these occurred in roughly 3.8% of finasteride patients versus 2.1% on placebo [1]. Post-marketing reports describe a subset of men who report persistent sexual side effects after stopping finasteride, sometimes called post-finasteride syndrome (PFS), though a definitive mechanistic explanation remains under investigation [16].

The FDA updated the finasteride label in 2012 to include information on high-grade prostate cancer risk based on the Prostate Cancer Prevention Trial (PCPT, N=18,882 men) [17]. PCPT showed finasteride reduced overall prostate cancer incidence by 24.8% but showed a higher rate of high-grade (Gleason 7 to 10) tumors in the finasteride group (6.4% vs. 5.1%, P<0.001). Subsequent analysis suggested this finding may partly reflect detection bias from prostate volume reduction, but the label language remains [17].

Wisconsin patients with a family history of prostate cancer should discuss PCPT findings explicitly with their prescriber before starting finasteride. That conversation does not cost anything. Skipping it might.

Monitoring Requirements and Their Cost Impact

Finasteride does not require routine lab monitoring for most patients. This distinguishes it favorably from other hormonal therapies. A baseline PSA is recommended before starting finasteride in men over 40, both to establish a reference point and because finasteride reduces PSA by approximately 50% after 6 months of use [1]. Interpreting future PSA results requires doubling the measured value to estimate the true PSA equivalent in an untreated prostate.

The American Urological Association guideline recommends documenting baseline PSA before finasteride initiation for BPH management [5]. That single lab draw, covered by most Wisconsin insurance plans as part of a preventive or diagnostic visit, is the primary monitoring cost for most patients.

Annual follow-up visits with a prescriber add to the overall cost of finasteride therapy. Telehealth follow-ups in Wisconsin typically cost $40 to $80 out-of-pocket if not covered by insurance, though many subscription telehealth platforms include follow-ups in the monthly fee.